<?xml version="1.0" encoding="UTF-8"?>
<p>Perhaps COVID-19 patients with longer GT sequences are at higher risk of developing the complications of COVID-19 including decreased vessel hemostasis (
 <xref ref-type="fig" rid="antioxidants-09-00636-f005">Figure 5</xref>). Further research needs to be done to determine if there is a correlation. Patients with Gilbert syndrome are known to have shorter GT sequences and elevated HO-1 levels and bilirubin [
 <xref rid="B46-antioxidants-09-00636" ref-type="bibr">46</xref>,
 <xref rid="B56-antioxidants-09-00636" ref-type="bibr">56</xref>,
 <xref rid="B57-antioxidants-09-00636" ref-type="bibr">57</xref>,
 <xref rid="B58-antioxidants-09-00636" ref-type="bibr">58</xref>]. These patients are well protected from cardiovascular disease due to a lower inflammatory state given the increase in bilirubin and HO-1 levels at baseline and during times of stress (e.g., fasting), which decreases ROS [
 <xref rid="B46-antioxidants-09-00636" ref-type="bibr">46</xref>,
 <xref rid="B56-antioxidants-09-00636" ref-type="bibr">56</xref>,
 <xref rid="B57-antioxidants-09-00636" ref-type="bibr">57</xref>,
 <xref rid="B58-antioxidants-09-00636" ref-type="bibr">58</xref>]. These findings further support that shorter GT sequences lead to a lower inflammatory state.
</p>
